prod:prod_dcx-login
New Ways. New Innovations. New Paths Towards Disease Management.
Cancer is Hard. Testing for it Shouldn’t Be.
Cepheid’s innovative oncology program offers a growing menu of molecular diagnostic tests that currently focus on cancers of the breast, bladder, and blood. Harnessing the power of quantitative PCR technology and the world’s most popular molecular diagnostics platform1, Cepheid oncology products provide on-site, on-demand, standardized, and reliable results.
Video
GeneXpert® : Enabling Oncology Teamwork
In this video, we see Dr. Craft consulting with Dr. Tanner, the on-site Pathologist, representing two of the members of the local cross-functional oncology team most familiar with the patient, Elizabeth.
Video
GeneXpert® : Enabling Oncology Teamwork
In this video, we see Dr. Craft consulting with Dr. Tanner, the on-site Pathologist, representing two of the members of the local cross-functional oncology team most familiar with the patient, Elizabeth.
With Cepheid’s proven “lab in a cartridge,” our tests give patients and their doctors peace of mind when it matters most. The pioneering mindset of our oncology team is bolstered by Cepheid’s strong molecular biology capabilities, extensive global infrastructure, and an unwavering commitment to scientific rigor.
Oncology Products
Xpert® BCR-ABL Ultra
Sensitive and quantitative monitoring of BCR-ABL mRNA in patients with chronic myelogenous leukemia (CML)
Discover a Better Path with Xpert BCR-ABL Ultra2
The high sensitivity of the Cepheid BCR-ABL test, Xpert BCR-ABL Ultra, allows for monitoring of disease even at low levels, thereby providing an essential aid for clinicians to manage their patients with CML, using IS-standardized molecular testing.
Xpert BCR-ABL Ultra Resources:
Xpert BCR-ABL Ultra Product Brochure
Sensitivity, precision and ease of use
More...
Xpert BCR-ABL Ultra Data Sheet
More...
Xpert BCR-ABL Key Features Flier
More...
Video
Cepheid and Max Foundation collaboration impacts CML patients around the globe
Our BCR-ABL test is playing a pivotal role in Cepheid’s vision of making molecular testing accessible to patients everywhere. In 2012, Cepheid partnered with The Max Foundation, an organization that channels humanitarian donations of life-saving oncology products to underserved populations in countries where those products are not locally available.
Through this collaboration of shared values, Cepheid offers compassion pricing of its GeneXpert IV instruments and Xpert BCR-ABL test for CML patients in specified low- and middle-income countries. Cepheid is also a proud sponsor of the Max Foundation initiative, My PCR, a patient driven program with the mission of educating all CML patients about the importance of monitoring their treatment with PCR testing.
Video
Cepheid and Max Foundation collaboration impacts CML patients around the globe
Our BCR-ABL test is playing a pivotal role in Cepheid’s vision of making molecular testing accessible to patients everywhere. In 2012, Cepheid partnered with The Max Foundation, an organization that channels humanitarian donations of life-saving oncology products to underserved populations in countries where those products are not locally available.
Through this collaboration of shared values, Cepheid offers compassion pricing of its GeneXpert IV instruments and Xpert BCR-ABL test for CML patients in specified low- and middle-income countries. Cepheid is also a proud sponsor of the Max Foundation initiative, My PCR, a patient driven program with the mission of educating all CML patients about the importance of monitoring their treatment with PCR testing.
In Here, We are Defining a New Era of Cancer Diagnostics
More than a decade ago, Cepheid set the standard for innovation in automated molecular diagnostics with the GeneXpert® System. The complicated process of nucleic acid extraction, amplification and detection is all carried out within each single use cartridge. By making complex technology easy to use, our GeneXpert® cartridge has become the symbol of the Molecular Revolution. Using advanced microfluidics, all aspects of the testing process are handled within the cartridge chambers, minimizing the risk of cross contamination. Each cartridge is standardized and comes with internal controls, making running extra standard curves obsolete.
Our oncology tests quickly and accurately characterize multiple cancer markers using the same game changing system.
_1.png)
GeneXpert Resources
Journey Inside the Cepheid GeneXpert® Cartridge - 3D Animation
More...
Meet our Game-Changing Platform
More...
GeneXpert System Brochure
More...
GeneXpert Infinity Systems Brochure
More...
References
1. Based on July 2019 market research conducted by Kalorama Information with sample respondents in select countries.
2. CE IVD and US-IVD. In Vitro Diagnostic Medical Device. Not available in all countries.